@article{86984fd7dcea45db8494e05201b37ac3,
title = "First survival data from the NIPU trial: A randomised, openlabel, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second-line treatment in patients with malignant mesothelioma",
author = "A. Helland and Haakensen, {V. D.} and Ojlert, {A. K.} and Thunold, {S. M. H.} and Nowak, {A. K.} and Chin, {W. L.} and O. Grundberg and Farooqi, {S. J.} and M. Lund-Iversen and Szejniuk, {W. M.} and Perez, {S. M. C.} and S{\o}rensen, {J. B.} and Bjaanaes, {M. M.}",
note = "Abstract No. LBA99; ESMO Congress 2023 ; Conference date: 20-10-2023 Through 24-10-2023",
year = "2023",
month = oct,
doi = "10.1016/j.annonc.2023.10.102",
language = "English",
volume = "34",
pages = "S1337",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Elsevier",
number = "Suppl. 2",
url = "https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2023",
}